These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
604 related articles for article (PubMed ID: 12000718)
1. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718 [TBL] [Abstract][Full Text] [Related]
2. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies. Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110 [TBL] [Abstract][Full Text] [Related]
3. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein]. Iwatsubo T Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099 [TBL] [Abstract][Full Text] [Related]
4. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347 [TBL] [Abstract][Full Text] [Related]
5. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533 [TBL] [Abstract][Full Text] [Related]
6. An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease. Uchihara T Neuropathology; 2017 Apr; 37(2):129-149. PubMed ID: 27862327 [TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of novel proteins in cortical lewy bodies. Leverenz JB; Umar I; Wang Q; Montine TJ; McMillan PJ; Tsuang DW; Jin J; Pan C; Shin J; Zhu D; Zhang J Brain Pathol; 2007 Apr; 17(2):139-45. PubMed ID: 17388944 [TBL] [Abstract][Full Text] [Related]
8. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403 [TBL] [Abstract][Full Text] [Related]
9. TIGAR inclusion pathology is specific for Lewy body diseases. López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647 [TBL] [Abstract][Full Text] [Related]
10. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies]. Orimo S Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627 [TBL] [Abstract][Full Text] [Related]
12. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival. Muqit MM; Davidson SM; Payne Smith MD; MacCormac LP; Kahns S; Jensen PH; Wood NW; Latchman DS Hum Mol Genet; 2004 Jan; 13(1):117-35. PubMed ID: 14645198 [TBL] [Abstract][Full Text] [Related]
13. The Lewy body in Parkinson's disease and related neurodegenerative disorders. Wakabayashi K; Tanji K; Odagiri S; Miki Y; Mori F; Takahashi H Mol Neurobiol; 2013 Apr; 47(2):495-508. PubMed ID: 22622968 [TBL] [Abstract][Full Text] [Related]
14. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease. Hou X; Fiesel FC; Truban D; Castanedes Casey M; Lin WL; Soto AI; Tacik P; Rousseau LG; Diehl NN; Heckman MG; Lorenzo-Betancor O; Ferrer I; Arbelo JM; Steele JC; Farrer MJ; Cornejo-Olivas M; Torres L; Mata IF; Graff-Radford NR; Wszolek ZK; Ross OA; Murray ME; Dickson DW; Springer W Autophagy; 2018; 14(8):1404-1418. PubMed ID: 29947276 [TBL] [Abstract][Full Text] [Related]
15. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831 [TBL] [Abstract][Full Text] [Related]
16. Clinical and neuropathological correlates of Lewy body disease. Hishikawa N; Hashizume Y; Yoshida M; Sobue G Acta Neuropathol; 2003 Apr; 105(4):341-50. PubMed ID: 12624787 [TBL] [Abstract][Full Text] [Related]
17. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies. Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907 [TBL] [Abstract][Full Text] [Related]
18. LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies. Grochowska MM; Carreras Mascaro A; Boumeester V; Natale D; Breedveld GJ; Geut H; van Cappellen WA; Boon AJW; Kievit AJA; Sammler E; ; Parchi P; Cortelli P; Alessi DR; van de Berg WDJ; Bonifati V; Mandemakers W Acta Neuropathol; 2021 Jul; 142(1):117-137. PubMed ID: 33913039 [TBL] [Abstract][Full Text] [Related]